Insulin Management

• US 20170076067A1
• Filed: 11/02/2016
• Published: 03/16/2017
• Est. Priority Date: 01/31/2014
• Status: Active Grant

• Current Assignee: Aseko, Inc.
• Original Assignee: Aseko, Inc.
• Inventors: Booth, Robert C., Hebblewhite, Harry
• Granted Patent: US 9,710,611 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61M 2005/14296 Pharmacokinetic models
• CPC Class Codes: A61M 2205/18 with alarm
• CPC Class Codes: A61M 2205/3553 remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 2205/3569 sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/50 with microprocessors or computers
• CPC Class Codes: A61M 2205/502 User interfaces, e.g. screens or keyboards
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 10/00 ICT specially adapted for the handling or processing of patient-related medical or healthcare data for medical reports G16H15/00; for therapies or health-improving plans G16H20/00; for the handling or processing of medical images G16H30/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

A method of managing insulin includes receiving blood glucose measurements on a computing device from a glucometer. The blood glucose measurements are separated by a time interval. The method includes determining, by the computing device, an insulin dose rate based on the blood glucose measurements and determining a blood glucose drop rate based on the blood glucose measurements and the time interval. The method also includes determining a blood glucose percentage drop based on the blood glucose measurements. The method includes decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose drop rate is greater than a threshold drop rate, and decreasing the time interval between blood glucose measurements by the glucometer when the blood glucose percentage drop is greater than a threshold percentage drop.

Claims

1. A method comprising:

receiving, at data processing hardware, sequential blood glucose measurements of a patient, the sequential blood glucose measurements comprising a current blood glucose measurement measured at a current time;

determining, by the data processing hardware, an intravenous insulin infusion rate based on the current blood glucose measurement;

determining, by the data processing hardware, whether the current blood glucose measurement is less than a threshold hypoglycemia blood glucose value for the patient;

determining, by the data processing hardware, a next time interval from the current time until a next time of a next scheduled blood glucose measurement for the patient based on the current blood glucose measurement, the next time interval comprising a hypoglycemia time interval when the current blood glucose measurement is less than the threshold hypoglycemia blood glucose value; and

executing, at the data processing hardware, an intravenous treatment process configured to display on a screen in communication with the data processing hardware a graphical user interface having a countdown timer indicating a remaining time until the next time of the next scheduled blood glucose measurement.

2. The method of claim 1, wherein the intravenous treatment process is further configured to display, in the graphical user interface, a blood glucose due message at the end of the next time interval indicating that the next scheduled blood glucose measurement for the patient is due.

3. The method of claim 1, wherein the intravenous treatment process is further configured to receive, in the graphical user interface, a blood glucose input from a medical professional for a next blood glucose measurement measured at a subsequent time after the current time.

4. The method of claim 1, wherein the intravenous treatment process is further configured to display, in the graphical user interface, the intravenous infusion rate indicating a number of units of insulin within a configured time interval for administration to the patient intravenously using an insulin administration device.

5. The method of claim 1, further comprising sending the intravenous insulin infusion rate from the data processing hardware to a remote insulation administration device in communication with the data processing hardware, and when the insulin administration device receives the intravenous insulin infusion rate, the insulin administration device configured to administer insulin to the patient intravenously using the intravenous insulin infusion rate.

6. The method of claim 1, wherein the intravenous treatment process is further configured to:

display, in the graphical user interface, a patient information input window; and

receive, in the patient information input window, patient information inputs from a medical professional to provide patient parameters for intravenous treatment of the patient, the patient parameters comprising;

a target blood glucose range for the patient comprising a range of blood glucose values between and including a lower limit blood glucose value and an upper limit blood glucose value greater than the lower limit blood glucose value;

the threshold hypoglycemia blood glucose value for the patient, the threshold hypoglycemia blood glucose value less than the lower limit blood glucose value of the target blood glucose range;

a low blood glucose percentage drop limit for the patient when the current blood glucose measurement is less than the lower limit blood glucose value of the target blood glucose range;

a regular blood glucose percentage drop limit for the patient when the current blood glucose measurement is greater than or equal to the lower limit blood glucose value of the target blood glucose range;

a blood glucose drop rate limit for the patient; and

a stable time period indicating a blood glucose concentration for the patient is stable in the target blood glucose range, the stable time period comprising one of a specified number of consecutive blood glucose measurements of the patient within the target blood glucose range or a recommended duration of time required for the current blood glucose measurement within the target blood glucose range to determine a blood glucose concentration for the patient is stable in the target blood glucose range.

7. The method of claim 6, wherein determining the next time interval comprises:

determining a blood glucose percentage drop based on the current blood glucose measurement and a previous blood glucose measurement of the sequential blood glucose measurements, the previous blood glucose measurement measured at a previous time earlier than the current time;

setting the next time interval to a short time interval greater than the hypoglycemia time interval when;

the current blood glucose measurement is greater than the threshold hypoglycemia blood glucose value and less than the lower limit blood glucose value of the target blood glucose range and the blood glucose percentage drop is greater than the low blood glucose percentage drop limit;

or

the current blood glucose measurement is greater than or equal to the lower limit blood glucose value of the target blood glucose range and the blood glucose percentage drop is greater than the regular blood glucose percentage drop limit.

8. The method of claim 6, wherein determining the next time interval comprises setting the next time interval to a long time interval when the current blood glucose measurement and one or more previous blood glucose measurements equal the specified number of consecutive blood glucose measurements within the target blood glucose range.

9. The method of claim 6, wherein determining the next time interval comprises setting the next time interval to a long time interval when the current blood glucose measurement has been within the blood glucose target range for a duration of time greater than the stable time period.

10. The method of claim 1, further comprising, when the current blood glucose measurement is less than the threshold hypoglycemia blood glucose value, determining, by the data processing hardware, a recommended dose of intravenous glucose for administration to the patient intravenously or oral glucose for ingestion by the patient.

11. The method of claim 1, wherein determining the intravenous insulin infusion rate comprises calculating:

IIR=(BG−

K)*M

wherein IIR is the intravenous insulin infusion rate, BG is the current blood glucose measurement, K is a constant, and M is a multiplier.

12. The method of claim 11, further comprising, in response to receiving an indication of patient solid food consumption, increasing the intravenous insulin infusion rate and maintaining the multiplier unchanged for at least two time intervals.

13. A system comprising:

a dosing controller in communication with the glucometer, the dosing controller including data processing hardware and memory hardware in communication with the data processing hardware, the dosing controller configured to perform operations comprising;

receiving sequential blood glucose measurements of a patient, the sequential blood glucose measurements comprising a current blood glucose measurement measured at a current time;

determining an intravenous insulin infusion rate based on the current blood glucose measurement;

determining whether the current blood glucose measurement is less than a threshold hypoglycemia blood glucose value for the patient;

determining a next time interval from the current time until a next time of a next scheduled blood glucose measurement for the patient based on the current blood glucose measurement, the next time interval comprising a hypoglycemia time interval when the current blood glucose measurement is less than the threshold hypoglycemia blood glucose value; and

executing an intravenous treatment process configured to display on a screen in communication with the data processing hardware a graphical user interface having a countdown timer indicating a remaining time until the next time of the next scheduled blood glucose measurement.

14. The system of claim 13, wherein the intravenous treatment process is further configured to display, in the graphical user interface, a blood glucose due message at the end of the next time interval indicating that the next scheduled blood glucose measurement for the patient is due.

15. The system of claim 13, wherein the intravenous treatment process is further configured to receive, in the graphical user interface, a blood glucose input from a medical professional for a next blood glucose measurement measured at a subsequent time after the current time.

16. The system of claim 13, wherein the intravenous treatment process is further configured to display, in the graphical user interface, the intravenous infusion rate indicating a number of units of insulin within a configured time interval for administration to the patient intravenously using an insulin administration device.

17. The system of claim 13, wherein the operations further comprise sending the intravenous insulin infusion rate from the data processing hardware to a remote insulation administration device in communication with the data processing hardware, and when the insulin administration device receives the intravenous insulin infusion rate, the insulin administration device configured to administer insulin to the patient intravenously using the intravenous insulin infusion rate.

18. The system of claim 13, wherein the intravenous treatment process is further configured to:

display, in the graphical user interface, a patient information input window; and

receive, in the patient information input window, patient information inputs from a medical professional to provide patient parameters for intravenous treatment of the patient, the patient parameters comprising;

a target blood glucose range for the patient comprising a range of blood glucose values between and including a lower limit blood glucose value and an upper limit blood glucose value greater than the lower limit blood glucose value;

the threshold hypoglycemia blood glucose value for the patient, the threshold hypoglycemia blood glucose value less than the lower limit blood glucose value of the target blood glucose range;

a low blood glucose percentage drop limit for the patient when the current blood glucose measurement is less than the lower limit blood glucose value of the target blood glucose range;

a regular blood glucose percentage drop limit for the patient when the current blood glucose measurement is greater than or equal to the lower limit blood glucose value of the target blood glucose range;

a blood glucose drop rate limit for the patient; and

a stable time period indicating a blood glucose concentration for the patient is stable in the target blood glucose range, the stable time period comprising one of a specified number of consecutive blood glucose measurements of the patient within the target blood glucose range or a recommended duration of time required for the current blood glucose measurement within the target blood glucose range to determine a blood glucose concentration for the patient is stable in the target blood glucose range.

19. The system of claim 18, wherein determining the next time interval comprises:

determining a blood glucose percentage drop based on the current blood glucose measurement and a previous blood glucose measurement of the sequential blood glucose measurements, the previous blood glucose measurement measured at a previous time earlier than the current time;

setting the next time interval to a short time interval greater than the hypoglycemia time interval when;

the current blood glucose measurement is greater than the threshold hypoglycemia blood glucose value and less than the lower limit blood glucose value of the target blood glucose range and the blood glucose percentage drop is greater than the low blood glucose percentage drop limit;

or

the current blood glucose measurement is greater than or equal to the lower limit blood glucose value of the target blood glucose range and the blood glucose percentage drop is greater than the regular blood glucose percentage drop limit.

20. The system of claim 18, wherein determining the next time interval comprises setting the next time interval to a long time interval when the current blood glucose measurement and one or more previous blood glucose measurements equal the specified number of consecutive blood glucose measurements within the target blood glucose range.

21. The system of claim 18, wherein determining the next time interval comprises setting the next time interval to a long time interval when the current blood glucose measurement has been within the blood glucose target range for a duration of time greater than the stable time period.

22. The system of claim 13, wherein the operations further comprise, when the current blood glucose measurement is less than the threshold hypoglycemia blood glucose value, determining a recommended dose of intravenous glucose for administration to the patient intravenously or oral glucose for ingestion by the patient.

23. The system of claim 13, wherein determining the intravenous insulin infusion rate comprises calculating:

IIR=(BG−

K)*M

wherein IIR is the intravenous insulin infusion rate, BG is the current blood glucose measurement, K is a constant, and M is a multiplier.

24. The system of claim 23, wherein the operations further comprise, in response to receiving an indication of patient solid food consumption, increasing the intravenous insulin infusion rate and maintaining the multiplier unchanged for at least two time intervals.